4//SEC Filing
Leicher Bruce 4
Accession 0001179110-18-006572
CIK 0001235010other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:11 PM ET
Size
8.5 KB
Accession
0001179110-18-006572
Insider Transaction Report
Form 4
Leicher Bruce
SVP & General Counsel
Transactions
- Exercise/Conversion
Common Stock
2018-05-08+1,345→ 172,188 total - Sale
Common Stock
2018-05-08$18.08/sh−471$8,516→ 171,717 total - Exercise/Conversion
Restricted Stock Units
2018-05-08−1,345→ 14,799 total→ Common Stock (1,345 underlying)
Footnotes (4)
- [F1]Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F3]Restricted Stock Units convert into common stock on a one-for-one basis.
- [F4]Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
Documents
Issuer
MOMENTA PHARMACEUTICALS INC
CIK 0001235010
Entity typeother
Related Parties
1- filerCIK 0001345695
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 5:11 PM ET
- Size
- 8.5 KB